Stockscreener 앱 받기
6.46
5.00%
-0.34
시간 외 거래:
6.38
-0.08
-1.24%
전일 마감가:
$6.80
열려 있는:
$6.76
하루 거래량:
23,604
Relative Volume:
0.18
시가총액:
$51.39M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-9.9385
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
-5.28%
1개월 성능:
-17.50%
6개월 성능:
+17.45%
1년 성능:
-78.18%
1일 변동 폭
$6.37
$6.9176
1주일 범위
$6.37
$6.9176
52주 변동 폭
$3.436
$31.00
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
6.46 | 54.10M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
592.51 | 217.70B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.40 | 161.70B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
669.99 | 54.02B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.95 | 38.58B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.37 | 38.39B | 15.90B | 1.28B | 2.21B | 7.2842 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Fundamentals Check: Why analysts recommend Modine Manufacturing Company MMF stockJuly 2025 Market Mood & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Biodesix CFO sells $22,794 in stock - MSN
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN
Options Flow: What dividend safety score for Biodesix Inc stock2025 Top Decliners & Low Risk High Win Rate Picks - moha.gov.vn
Analyst Calls: Why analysts upgrade Biodesix Inc stock2025 Price Action Summary & Growth Focused Entry Reports - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Biodesix Inc. stock split again soonJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - Улправда
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Is Biodesix Inc. stock attractive for retirement portfoliosGap Down & Safe Capital Growth Stock Tips - Улправда
Why Biodesix Inc. stock is considered a top pick2025 Valuation Update & Precise Trade Entry Recommendations - DonanımHaber
Price Action: Can Biodesix Inc. stock continue upward trendEarnings Recap Summary & AI Enhanced Trading Signals - Улправда
What dividend safety score for Biodesix Inc. stockIPO Watch & Weekly Return Optimization Alerts - DonanımHaber
Why retail investors favor Biodesix Inc. stockTrade Performance Summary & Step-by-Step Swing Trade Plans - DonanımHaber
Is Biodesix Inc. stock affected by interest rate hikes2025 Technical Patterns & Smart Swing Trading Alerts - Улправда
Will Biodesix Inc. stock attract ESG investors2025 Major Catalysts & Fast Moving Trade Plans - DonanımHaber
Biodesix and Bio-Rad Laboratories Team Up on Droplet Digital PCR Assays - Medical Product Outsourcing
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Biodesix Stock Built to Withstand More Downside? - Trefis
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Loss Report: Can Biodesix Inc stock continue upward trendTake Profit & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Would You Still Hold Biodesix Stock If It Fell 30%? - Trefis
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade - Eastern Progress
BDSX FinancialsIncome Statement - Quiver Quantitative
Biodesix, Inc. to Present Clinical Data for Nodify Lung® Tests and New ESR1 Assay at Major Oncology Conferences - Quiver Quantitative
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings - GlobeNewswire
Will Biodesix Inc. stock deliver strong dividend growth2025 Major Catalysts & Safe Capital Growth Plans - Newser
Will Biodesix Inc. stock gain from strong economy2025 Macro Impact & Daily Volume Surge Signals - Newser
Biodesix, Inc.'s (NASDAQ:BDSX) Shares Leap 27% Yet They're Still Not Telling The Full Story - simplywall.st
Macro Review: Is Biodesix Inc. stock affected by interest rate hikesPortfolio Return Summary & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Biodesix Inc. stock continue upward trendWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Biodesix Reports Strong Q3 2025 Revenue Growth - MSN
Is Biodesix Inc. stock attractive for hedge fundsMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
What drives Biodesix Inc stock priceEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
Can OBSC Perfection Limited Beat EPS Estimates in the Next QuarterTechnical Breakout Signals & Free High Impact Stock Picks - earlytimes.in
Is Biodesix Inc. a candidate for recovery playJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Advanced analytics toolkit walkthrough for Biodesix Inc.2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Top chart patterns to watch in Biodesix Inc.Quarterly Market Summary & Reliable Breakout Forecasts - newser.com
Is Biodesix Inc. stock a bargain at current levelsWeekly Market Summary & Stock Market Timing Techniques - newser.com
Biodesix Inc. recovery potential after sell offJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Is Biodesix Inc. stock a good choice for value investorsPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Biodesix Inc. stock a defensive play in 2025Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
0.11%
자본화:
|
볼륨(24시간):